News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,787 Results
Type
Article (40066)
Company Profile (288)
Press Release (665433)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (206534)
Career Advice (2020)
Deals (35736)
Drug Delivery (95)
Drug Development (82114)
Employer Resources (174)
FDA (16220)
Job Trends (14997)
News (349027)
Policy (32737)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2562)
Accelerated approval (5)
Adcomms (20)
Allergies (84)
Alliances (50076)
ALS (90)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (124)
Approvals (16226)
Artificial intelligence (247)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11738)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (205)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (274)
Cancer (2203)
Cardiovascular disease (175)
Career advice (1685)
Career pathing (30)
CAR-T (145)
Cell therapy (409)
Cervical cancer (19)
Clinical research (66804)
Collaboration (828)
Compensation (529)
Complete response letters (19)
COVID-19 (2596)
CRISPR (37)
C-suite (237)
Cystic fibrosis (101)
Data (2139)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (263)
Diagnostics (6371)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87374)
Editorial (36)
Employer branding (22)
Employer resources (148)
Events (114255)
Executive appointments (715)
FDA (17442)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (744)
Gene editing (100)
Generative AI (19)
Gene therapy (288)
GLP-1 (712)
Government (4427)
Grass and pollen (5)
Guidances (53)
Healthcare (18861)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (112)
Indications (29)
Infectious disease (2738)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (94)
Interviews (315)
IPO (16686)
IRA (40)
Job creations (3684)
Job search strategy (1431)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (16)
Legal (7936)
Liver cancer (73)
Lung cancer (313)
Lymphoma (150)
Machine learning (6)
Management (58)
Manufacturing (297)
MASH (66)
Medical device (13374)
Medtech (13379)
Mergers & acquisitions (19584)
Metabolic disorders (672)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1903)
NextGen: Class of 2025 (6539)
Non-profit (4491)
Northern California (2613)
Now hiring (39)
Obesity (359)
Opinion (204)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (21)
Patents (230)
Patient recruitment (106)
Peanut (46)
People (57940)
Pharmaceutical (74)
Pharmacy benefit managers (18)
Phase I (20834)
Phase II (29463)
Phase III (21841)
Pipeline (1143)
Policy (135)
Postmarket research (2569)
Preclinical (8834)
Press Release (64)
Prostate cancer (101)
Psychedelics (30)
Radiopharmaceuticals (253)
Rare diseases (375)
Real estate (5997)
Recruiting (66)
Regulatory (22416)
Reports (46)
Research institute (2332)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2244)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3621)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (29)
United States (22729)
Vaccines (684)
Venture capitalists (41)
Weight loss (232)
Women's health (35)
Worklife (15)
Date
Today (97)
Last 7 days (670)
Last 30 days (2337)
Last 365 days (33064)
2025 (10028)
2024 (35564)
2023 (40473)
2022 (51634)
2021 (56244)
2020 (54470)
2019 (46902)
2018 (35316)
2017 (32510)
2016 (31951)
2015 (38020)
2014 (31850)
2013 (26770)
2012 (28944)
2011 (29608)
2010 (27669)
Location
Africa (728)
Alabama (57)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (38757)
Australia (6291)
California (5971)
Canada (1977)
China (525)
Colorado (265)
Connecticut (269)
Delaware (142)
Europe (83932)
Florida (891)
Georgia (202)
Idaho (57)
Illinois (525)
India (25)
Indiana (306)
Iowa (11)
Japan (158)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (880)
Massachusetts (4489)
Michigan (216)
Minnesota (386)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (62)
New Jersey (1706)
New Mexico (29)
New York (1703)
North Carolina (1001)
North Dakota (7)
Northern California (2613)
Ohio (199)
Oklahoma (14)
Oregon (35)
Pennsylvania (1338)
Puerto Rico (12)
Rhode Island (32)
South America (1109)
South Carolina (22)
South Dakota (1)
Southern California (2244)
Tennessee (101)
Texas (887)
Utah (177)
Virginia (145)
Washington D.C. (62)
Washington State (551)
West Virginia (3)
Wisconsin (52)
705,787 Results for "alder biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
Gain Therapeutics, Inc. today releases the following letter to stockholders from its President and Chief Executive Officer Matthias Alder.
January 31, 2024
·
13 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
BioMidwest
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will be hosting a virtual meeting of its stockholders at 1pm ET on Monday, July 8th, 2024.
June 20, 2024
·
5 min read
Press Releases
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 2, 2025
·
2 min read
Business
Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer
Gain Therapeutics, Inc. today announced that Matthias Alder, the Company’s current Chief Operating Officer, has been appointed as the Company’s Chief Executive Officer, effective immediately.
September 20, 2022
·
5 min read
Press Releases
HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Different Cancer Killing Payloads to Overcome Limitations of Current ADCs
April 21, 2025
·
2 min read
Deals
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
Eiger BioPharmaceuticals, Inc. today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30.
January 4, 2024
·
5 min read
Press Releases
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
February 26, 2025
·
4 min read
BioMidwest
Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders
Provectus Biopharmaceuticals, Inc. announced that its 2024 annual stockholder meeting, including meeting activities and a company update, will be accessible by Zoom Webinar.
June 13, 2024
·
5 min read
1 of 70,579
Next
